Literature DB >> 7355700

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.

S Halprin, W Frishman, M Kirschner, J Strom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7355700     DOI: 10.1016/0002-8703(80)90354-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  3 in total

Review 1.  Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-09       Impact factor: 3.727

2.  Improvement in angina pectoris with alpha adrenoceptor blockade.

Authors:  P Collins; D Sheridan
Journal:  Br Heart J       Date:  1985-05

3.  Oral labetalol in the management of stable angina pectoris in normotensive patients.

Authors:  J W Upward; F Akhras; G Jackson
Journal:  Br Heart J       Date:  1985-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.